Cargando…
Fe(3+)-binding transferrin nanovesicles encapsulating sorafenib induce ferroptosis in hepatocellular carcinoma
BACKGROUND: Ferroptosis, iron-dependent cell death, is an established mechanism for cancer suppression, particularly in hepatocellular carcinoma (HCC). Sorafenib (SOR), a frontline drug for the treatment of HCC, induces ferroptosis by inhibiting the Solute Carrier family 7 member 11 (SLC7A11), with...
Autores principales: | Xiao, Youmei, Xu, Zhanxue, Cheng, Yuan, Huang, Rufan, Xie, Yuan, Tsai, Hsiang-i, Zha, Hualian, Xi, Lifang, Wang, Kai, Cheng, Xiaoli, Gao, Yanfeng, Zhang, Changhua, Cheng, Fang, Chen, Hongbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314404/ https://www.ncbi.nlm.nih.gov/pubmed/37391845 http://dx.doi.org/10.1186/s40824-023-00401-x |
Ejemplares similares
-
PD-1 Cellular Nanovesicles Carrying Gemcitabine to Inhibit the Proliferation of Triple Negative Breast Cancer Cell
por: Zha, Hualian, et al.
Publicado: (2022) -
Plant exosomes fused with engineered mesenchymal stem cell‐derived nanovesicles for synergistic therapy of autoimmune skin disorders
por: Huang, Rufan, et al.
Publicado: (2023) -
Polydopamine Decorated Microneedles with Fe‐MSC‐Derived Nanovesicles Encapsulation for Wound Healing
por: Ma, Wenjuan, et al.
Publicado: (2022) -
Liposomal Nanovesicles for Efficient Encapsulation
of Staphylococcal Antibiotics
por: Gonzalez Gomez, Azucena, et al.
Publicado: (2019) -
Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy
por: Ke, You, et al.
Publicado: (2018)